RhumbLine Advisers
SVRA icon

RhumbLine Advisers’s Savara SVRA Stock Holding History

RhumbLine Advisers’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Buy
186,071
+28,929
+18% +$155K ﹤0.01% 2231
2026
Q1 		$858K Buy
157,142
+4,367
+3% +$24.3K ﹤0.01% 2277
2025
Q4 		$921K Sell
152,775
-4,792
-3% -$23.5K ﹤0.01% 2278
2025
Q3 		$563K Sell
157,567
-12,609
-7% -$37.3K ﹤0.01% 2619
2025
Q2 		$388K Buy
170,176
+16,634
+11% +$45.2K ﹤0.01% 2842
2025
Q1 		$425K Buy
153,542
+12,117
+9% +$33.5K ﹤0.01% 2673
2024
Q4 		$434K Buy
141,425
+9,041
+7% +$31.5K ﹤0.01% 2762
2024
Q3 		$561K Sell
132,384
-2,164
-2% -$9.56K ﹤0.01% 2627
2024
Q2 		$542K Buy
134,548
+619
+0.5% +$2.75K ﹤0.01% 2620
2024
Q1 		$667K Buy
133,929
+3,865
+3% +$18.7K ﹤0.01% 2484
2023
Q4 		$611K Buy
130,064
+8,530
+7% +$32.7K ﹤0.01% 2551
2023
Q3 		$459K Buy
121,534
+21,496
+21% +$76.6K ﹤0.01% 2661
2023
Q2 		$320K Buy
+100,038
New +$235K ﹤0.01% 2966
2021
Q2 		– Sell
-70,148
Closed -$146K – 3099
2021
Q1 		$146K Sell
70,148
-700
-1% -$1.2K ﹤0.01% 2891
2020
Q4 		$81K Buy
70,848
+10,135
+17% +$12.2K ﹤0.01% 2989
2020
Q3 		$66K Sell
60,713
-9,850
-14% -$16.9K ﹤0.01% 2935
2020
Q2 		$176K Buy
70,563
+29,886
+73% +$72.7K ﹤0.01% 2814
2020
Q1 		$86K Buy
40,677
+1,101
+3% +$3.02K ﹤0.01% 2805
2019
Q4 		$177K Sell
39,576
-704
-2% -$847 ﹤0.01% 2781
2019
Q3 		$107K Buy
40,280
+395
+1% +$987 ﹤0.01% 2876
2019
Q2 		$95K Buy
39,885
+3,581
+10% +$31.8K ﹤0.01% 2933
2019
Q1 		$268K Sell
36,304
-786
-2% -$5.92K ﹤0.01% 2605
2018
Q4 		$281K Buy
37,090
+13,120
+55% +$118K ﹤0.01% 2576
2018
Q3 		$268K Buy
23,970
+90
+0.4% +$1.03K ﹤0.01% 2575
2018
Q2 		$270K Buy
+23,880
New +$240K ﹤0.01% 2582

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

RhumbLine Advisers's SVRA Position: Q2 2026 in Review

RhumbLine Advisers increased its Savara (SVRA) stake by 18% in Q2 2026, buying an estimated $155K and bringing the position to 186,071 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2231.

RhumbLine Advisers first reported a position in SVRA in Q2 2018 and has held it in 25 quarters since. 181 funds tracked by Wall St. Rank hold SVRA as of Q2 2026.

  • RhumbLine Advisers held 186,071 shares of Savara worth $1.15M as of Q2 2026.
  • RhumbLine Advisers bought 28,929 Savara shares in Q2 2026, an estimated $155K.
  • Savara made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2231 holding.
  • RhumbLine Advisers first reported a position in Savara in Q2 2018 and has held it in 25 quarters since.
  • 181 funds tracked by Wall St. Rank held Savara as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.